THERESA HARRINGTON STUKUS: Open Payments
NPI 1104801844 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,968 in 51 payments from 11 companies in 2025. Trend: 2023 $218 · 2024 $18,820 · 2025 $19,968
Speaker / faculty: $9,661Travel & lodging: $5,422Consulting: $4,050Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 27 | $13,328 |
| PFIZER INC. | 9 | $6,282 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| BeOne Medicines USA, Inc. | 3 | $78 |
| Genentech USA, Inc. | 2 | $50 |
| Daiichi Sankyo Inc. | 1 | $29 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| ACCORD HEALTHCARE, INC. | 1 | $19 |
Products named: Trodelvy, IBRANCE, KISQALI, BRUKINSA, Itovebi, Enhertu, TEVIMBRA, SCEMBLIX.
Industry payments across VA — which companies pay providers there.
